SS Innovations Showcases SSi Mantra Telesurgery Capabilities at October 2026 Conferences

SS Innovations (SSII) showcased its SSi Mantra robotic system and SSi MantrAsana remote-surgeon console in telesurgeries at two October 2026 conferences.

Rhea-AI Summary

SS Innovations (SSII) showcased its SSi Mantra robotic system and SSi MantrAsana remote-surgeon console in telesurgeries at two October 2026 conferences.

At the EACTS Annual Meeting in Barcelona, CEO Dr. Sudhir Srivastava performed a remote cardiac procedure on a patient in Bengaluru, India, approximately 7,500 miles away, with patient-side surgical support. At the SRS India Conference in New Delhi, four surgeons completed four separate robotic-assisted telesurgeries in live demonstrations. As of October 23, 2026, 205 telesurgeries, including cardiac procedures, had been performed using SSi Mantra.

Argus 15 min delay 8 alerts

+6.64% vs previous close $2.40 last price 4.6x rel. volume Open Argus

Details

Market move: SSII +6.64% vs previous close. Telesurgery demonstrations

+10.4% Peak in 27 min

$2.26 – $2.65 Day Range

$481.05M Mkt Cap at Last Price

On Oct 26, the day this news came out, the latest delayed price for SSII is 6.64% above the previous close. Argus tracked a peak move of +10.4% during the session. Our momentum scanner has recorded 8 alerts for this stock so far that day. The latest delayed price is $2.40. Relative volume is very high at 4.6x the average.

Data tracked by StockTitan Argus (15 min delayed). Upgrade to Gold for real-time data.

Key Figures

Telesurgeries demonstrated: 4 separate telesurgeries Remote procedure distance: Approximately 7,500 miles (12,000 kilometers) Cumulative telesurgeries: 205 telesurgeries

Telesurgeries demonstrated

4 separate telesurgeries

Live demonstrations at the SRS India Conference

Remote procedure distance

Approximately 7,500 miles (12,000 kilometers)

Cardiac telesurgery from Barcelona to a patient in Bengaluru

Cumulative telesurgeries

205 telesurgeries

Performed with the SSi Mantra as of October 23, 2026

Historical Context

1 past event · Latest: Jul 17

1 event

1. Jul 17

   Telesurgery showcase

   24h Move

   +0.8%

   Reported 178 cumulative telesurgeries as of July 6 and planned a live partial-nephrectomy broadcast.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

atrial septal defect, partial nephrectomy, hemicolectomy, pyeloplasty, +1 more

5 terms

atrial septal defect medical

"robotic atrial septal defect (ASD) procedure"

Atrial septal defect is a hole in the wall that separates the two upper chambers of the heart, allowing blood to mix between them. Like a doorway that shouldn’t be there, it can make the heart work harder and lead to symptoms or the need for procedures. Investors care because the condition drives demand for diagnostic tests, devices, surgeries and therapies, affects healthcare costs and reimbursement trends, and can influence clinical trial and regulatory risk for related companies.

partial nephrectomy medical

"a right partial nephrectomy"

Surgical removal of only the diseased portion of a kidney while leaving the rest of the organ intact, usually to excise a tumor and preserve kidney function. Think of it as cutting out a rotten spot in an apple while saving the healthy fruit. It matters to investors because procedure rates, outcomes, device use, hospital stays and reimbursement influence revenue and market demand for surgical tools, imaging, and related therapies.

hemicolectomy medical

"a right hemicolectomy"

Surgical removal of one side or a defined segment of the large intestine (colon). A hemicolectomy removes either the right or left portion of the colon (or another named segment), usually with reconnecting the remaining ends (an anastomosis) or, less commonly, creating a temporary or permanent stoma; when performed for cancer it typically includes nearby lymph node removal. It is distinct from a total colectomy, which removes the entire colon, and can be done through open or minimally invasive techniques.

pyeloplasty medical

"a left-sided pyeloplasty on a pediatric patient"

Surgical repair of a blockage where the kidney's drainage area meets the tube that carries urine to the bladder (the ureteropelvic junction); surgeons remove the narrowed segment and reconnect healthy tissue so urine can flow normally. Like fixing a clogged section of plumbing between a sink and its drain, the procedure restores function and can be done through open, laparoscopic, or robotic approaches. It matters to investors because procedure volume, device use, reimbursement and clinical outcomes affect hospitals, medical-device makers and healthcare revenues.

sentinel lymph node biopsy medical

"a sentinel lymph node biopsy"

A sentinel lymph node biopsy is a surgical procedure that removes and tests the first lymph node(s) that drain fluid from a tumor to see if cancer has spread. Think of it as checking the first security checkpoint after a breach; a negative result often means less extensive surgery and lower treatment costs, while a positive result can change therapy, prognosis, regulatory decisions and market demand for related diagnostics and treatments, making it important to investors.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

FORT LAUDERDALE, Fla., Oct. 26, 2026 (GLOBE NEWSWIRE) -- via IBN – SS Innovations International, Inc. (the “Company” or “SS Innovations”) (NASDAQ: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced that the Company’s SSi Mantra surgical robotic system (the “SSi Mantra”) and SSi MantrAsana tele-surgeon console (the “SSi MantrAsana”) were showcased in successful telesurgeries performed in October 2026 during the European Association for Cardio-Thoracic Surgery (“EACTS”) Annual Meeting in Barcelona, Spain and the Society of Robotic Surgery India (“SRS India”) Conference in New Delhi, India. 

At the EACTS Annual Meeting, the Company’s Chairman of the Board and Chief Executive Officer, Dr. Sudhir Srivastava, successfully performed a robotic-assisted cardiac telesurgery utilizing the SSi Mantra and SSi MantrAsana tele-surgeon console live on stage in Barcelona, approximately 7,500 miles (12,000 kilometers) from the patient at Sri Madhusudan Sai Institute of Medical Sciences and Research in Bengaluru, India.  Dr. Srivastava remotely performed a robotic atrial septal defect (ASD) procedure with patient-side support from Dr. Lalit Malik, Chief Cardiac Surgeon of Manipal Hospital Jaipur.  The EACTS Annual Meeting is the largest global gathering of leaders in the cardiothoracic surgical community, bringing together thousands of industry professionals each year.

At the inaugural SRS India Conference, four surgeons successfully completed four separate robotic-assisted telesurgeries featuring the SSi Mantra and SSi MantrAsana tele-surgeon console in live demonstrations.  The remote procedures performed or broadcast live at the event included: a right partial nephrectomy, a right hemicolectomy, a left-sided pyeloplasty on a pediatric patient, and a modified radical hysterectomy with a sentinel lymph node biopsy.  Organized by the Society of Robotic Surgery and officially inaugurated by Dr. Jitendra Singh, India’s Minister of Science and Technology, the SRS India Conference convenes leading surgeons, delegates, researchers and industry partners in New Delhi each year.  For video highlights of the telesurgeries showcased at the SRS India Conference, please visit: link.  

Dr. Srivastava commented, “We were grateful for the opportunity to demonstrate the advanced telesurgery capabilities of our SSi Mantra surgical robotic system and SSi MantrAsana tele-surgeon console this month at the 40th EACTS Annual Meeting in Barcelona and the inaugural SRS India Conference in New Delhi.  As a pioneer and leader in telesurgery technology, SS Innovations aims to dismantle traditional geographic barriers and democratize access to world class health care.”

The SSi MantrAsana has been engineered for real-time remote procedures through ultra-low latency connectivity, high-definition visualization, and precise instrument control.

As of October 23, 2026, a total of 205 telesurgeries, including intricate cardiac procedures, have been performed with the SSi Mantra surgical robotic system.  

About SS Innovations
SS Innovations International, Inc. (Nasdaq: SSII) develops innovative surgical robotic technologies with a vision to make the benefits of robotic surgery affordable and accessible to a larger segment of the global population. The Company’s product range includes its proprietary “SSi Mantra” surgical robotic system and its comprehensive suite of “SSi Mudra” surgical instruments, which support a variety of surgical robotic procedures including cardiac surgery.  Headquartered in India, SS Innovations is a U.S. company focused on expanding the global presence of its technologically advanced, user-friendly, and cost-effective surgical robotic solutions.  Visit the Company’s website at ssinnovations.com or LinkedIn for more information and updates.

About the SSi Mantra
The SSi Mantra surgical robotic system is a modular, multi-arm system with advanced technology features, including: 3 to 5 modular robotic arms, an open-faced ergonomic surgeon command center, a large 3D 4K monitor, a touch panel monitor for all patient related information display, a virtual real-time image of the robotic patient side arm carts, and the ability for superimposition of 3D models of diagnostic imaging. The optional SSi MantrAsana tele-surgeon console is a portable, compact alternative to the SSi Mantra’s standard surgeon command center that is intended to provide equivalent control functionality while enabling enhanced portability, ergonomic flexibility, and telesurgery capability. The SSi Mantra utilizes over 40 different types of robotic endo-surgical instruments to support different specialties, including cardiac surgery, and 5mm instruments for the pediatric population and ENT surgeries. A vision cart is designed to provide the table-side team with the same magnified 3D 4K view as the surgeon to provide better safety and efficiency. The SSi Mantra has been clinically validated in India in more than 190 different types of surgical procedures.

Forward Looking Statements
This press release may contain statements that are not historical facts and are considered forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. The words “anticipate,” “assume,” “believe,” “estimate,” “expect,” “will,” “intend,” “may,” “plan,” “project,” “should,” “could,” “seek,” “designed,” “potential,” “forecast,” “target,” “objective,” “goal,” or the negatives of such terms or other similar expressions to identify such forward-looking statements. These statements relate to future events or SS Innovations’ future financial performance and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements.

Investor Contact:
The Equity Group       
Kalle Ahl, CFA             
T: (303) 953-9878       
kalle.ahl@theequitygroup.com

Devin Sullivan, Managing Director
T: (212) 836-9608
devin.sullivan@theequitygroup.com

Media Contact:
RooneyPartners LLC
Kate Barrette
T: (212) 223-0561
kbarrette@rooneypartners.com

Attachment

• Live Cardiac Telesurgery Performed from EACTS Annual Meeting Utilizing the SSi Mantra